Table 3 Incidence of tumors in B6C3F1 mice between control group and 500 mG exposed group
From: Effects of extremely low-frequency electromagnetic fields (ELF-EMF) exposure on B6C3F1 mice
Location | Tumor | Male | Female | ||
|---|---|---|---|---|---|
500 mG | Control | 500 mG | Control | ||
Total number of B6C3F1 mice | 24 | 30 | 42 | 32 | |
Haematopoietic organ | Chronic myelogenous leukemia | 0 | 0 | 3 (7 %) | 0 |
Malignant lymphoma | 0 | 0 | 0 | 0 | |
Liver | Hepatocellular carcinoma | 2 (8 %) | 4 (13 %) | 0 | 0 |
Adenomatous hyperplasia | 6 (25 %) | 7 (23 %) | 0 | 0 | |
Haemangioma | 3 (13 %) | 0 | 0 | 0 | |
Gastrointestinal tract | Gastric or intestinal tumor | 0 | 0 | 0 | 0 |
Lung | Adenocarcinoma | 2 (8 %) | 2 (7 %) | 0 | 1 (3 %) |
Adenoma | 0 | 1 (3 %) | 0 | 0 | |
Eye | Harderian gland adenoma | 0 | 1 (3 %) | 0 | 0 |
Skin | Eccrine adenocarcinoma | 0 | 0 | 1 (2 %) | 0 |
Ovary | Cystic adenoma | 0 | 0 | 1 (2 %) | 1 (3 %) |
Uterus | Stromal sarcoma | 0 | 0 | 1 (2 %) | 0 |
Testis | Adenoma | 0 | 1 (3 %) | 0 | 0 |